These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2757901)

  • 1. Vigabatrin in the treatment of epilepsy in children.
    Livingston JH; Beaumont D; Arzimanoglou A; Aicardi J
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):109S-112S. PubMed ID: 2757901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
    Remy C; Beaumont D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin in intractable childhood epilepsy: a retrospective study.
    Gibbs JM; Appleton RE; Rosenbloom L
    Pediatr Neurol; 1992; 8(5):338-40. PubMed ID: 1418176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities.
    Armour DJ; Fidler C; Wright EC; Balarajan S
    Seizure; 1992 Sep; 1(3):157-62. PubMed ID: 1344760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R; Herranz JL; Valdizán EM; Armijo JA
    Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy.
    Tartara A; Manni R; Galimberti CA; Morini R; Mumford JP; Iudice A; Perucca E
    Acta Neurol Scand; 1992 Sep; 86(3):247-51. PubMed ID: 1414241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy.
    Tassinari CA; Michelucci R; Ambrosetto G; Salvi F
    Arch Neurol; 1987 Sep; 44(9):907-10. PubMed ID: 2887152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vigabatrin in the management of infantile epileptic syndromes.
    Appleton RE
    Neurology; 1993 Nov; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin in childhood epilepsy.
    Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
    Grant SM; Heel RC
    Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study.
    Luna D; Dulac O; Pajot N; Beaumont D
    Epilepsia; 1989; 30(4):430-7. PubMed ID: 2502384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
    Coppola G; Terraciano AM; Pascotto A
    Brain Dev; 1997 Nov; 19(7):459-63. PubMed ID: 9408591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.
    Mumford JP; Dam M
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):101S-107S. PubMed ID: 2667602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study.
    Feucht M; Brantner-Inthaler S
    Epilepsia; 1994; 35(5):993-8. PubMed ID: 7925171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.